Search

Samia Naccache Phones & Addresses

  • Seattle, WA
  • Los Angeles, CA
  • 872 Filbert St, San Francisco, CA 94133 (858) 245-0048
  • 2112 Balboa Ave, Pacific Beach, CA 92109 (858) 581-9441
  • San Diego, CA
  • Claremont, CA
  • Tempe, AZ
  • Mesa, AZ

Work

Company: Labcorp Aug 2018 Position: Technical director, microbiology

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Uc San Diego 2001 to 2006 Specialities: Biology

Ranks

Certificate: License 2220

Industries

Hospital & Health Care

Resumes

Resumes

Samia Naccache Photo 1

Technical Director, Microbiology

View page
Location:
605 10Th St, Seattle, WA 98057
Industry:
Hospital & Health Care
Work:
Labcorp
Technical Director, Microbiology

Children's Hospital Los Angeles (Chla) Jul 2016 - Jun 2018
Medical Microbiology Fellow

Ucsf Aug 2013 - Jul 2016
Associate Specialist

Ucsf Apr 2010 - Jul 2013
Postdoctoral Research Fellow

The Scripps Research Institute Nov 2006 - Sep 2009
Postdoctoral Research Associate
Education:
Uc San Diego 2001 - 2006
Doctorates, Doctor of Philosophy, Biology
Pomona College 1997 - 2001
Bachelors, Bachelor of Arts, Biology
University of Glasgow 2000 - 2000
Certifications:
License 2220
Clinical Microbiologist Scientist
Public Health Microbiologist
Technologist In Microbiology

Publications

Us Patents

Pathogen Detection Using Next Generation Sequencing

View page
US Patent:
20200243161, Jul 30, 2020
Filed:
Jan 29, 2020
Appl. No.:
16/776405
Inventors:
- Oakland CA, US
Samia Naccache - San Francisco CA, US
Scot Federman - Portola Valley CA, US
Doug Stryke - Albany CA, US
Steve Miller - San Mateo CA, US
Erik Samayoa - San Francisco CA, US
International Classification:
G16B 30/00
G16B 20/00
Abstract:
Embodiments are directed to systems and methods for pathogen detection using next-generation sequencing (NGS) analysis of a sample. Embodiments may apply alignment algorithms (e.g., SNAP and/or RAPSearch alignment algorithms) to align individual sequence reads from a sample in a next-generation sequencing (NGS) dataset against reference genome entries in a classified reference genome database. Embodiments of the present invention may include classifying, filtering, and displaying results to a clinician that can then quickly and easily obtain the results of the sequencing to identify a pathogen or other genetic material in a sample that is being tested. A negative sample and a corresponding database can be used to remove contaminants from a list of candidate pathogens. Thus, embodiments are directed to a system that is configured to filter the results of a sequencing alignment and classify a sample quickly.

Pathogen Detection Using Next Generation Sequencing

View page
US Patent:
20180203976, Jul 19, 2018
Filed:
Mar 9, 2018
Appl. No.:
15/917286
Inventors:
- Oakland CA, US
Samia NACCACHE - San Francisco CA, US
Scot FEDERMAN - Portola Valley CA, US
Doug STRYKE - Albany CA, US
Steve MILLER - San Mateo CA, US
Erik SAMAYOA - San Francisco CA, US
International Classification:
G06F 19/22
G06F 19/18
Abstract:
Embodiments are directed to systems and methods for pathogen detection using next-generation sequencing (NGS) analysis of a sample. Embodiments may apply alignment algorithms (e.g., SNAP and/or RAPSearch alignment algorithms) to align individual sequence reads from a sample in a next-generation sequencing (NGS) dataset against reference genome entries in a classified reference genome database. Embodiments of the present invention may include classifying, filtering, and displaying results to a clinician that can then quickly and easily obtain the results of the sequencing to identify a pathogen or other genetic material in a sample that is being tested. A negative sample and a corresponding database can be used to remove contaminants from a list of candidate pathogens. Thus, embodiments are directed to a system that is configured to filter the results of a sequencing alignment and classify a sample quickly.
Samia Nidal Naccache from Seattle, WA, age ~44 Get Report